Northeast Financial Consultants Inc Moderna, Inc. Transaction History

Northeast Financial Consultants Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$118.07 - $194.18 $260,934 - $429,137	2,210 New	2,210 $261,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $126,460 - $235,050	-1,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $541,968 - $884,424	-2,400 Reduced 70.59%	1,000 $254,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $532,560 - $1.16 Million	2,400 Added 240.0%	3,400 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $129,910 - $234,980	1,000 New	1,000 $235,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.